von Moltke Lisa

CIK 00018085923 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808592

Recent Transactions

40 trades

Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2026-06-15+150,000→ 150,000 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2025-04-15+400,000→ 400,000 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2025-02-18$0.81/sh−4,416→ 39,875 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2025-02-15+8,907→ 44,291 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2025-02-15−8,907→ 26,718 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2025-02-15−2,969→ 23,750 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2025-02-15+2,969→ 35,384 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2025-02-07+650,000→ 650,000 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-11-18$0.54/sh−977→ 32,415 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-11-15−2,969→ 26,719 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-11-15+2,969→ 33,392 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-10-28$0.69/sh−4,334→ 30,423 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-10-27+13,744→ 34,757 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-10-27−13,744→ 0 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-08-16$0.84/sh−973→ 21,013 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-08-15+2,969→ 21,986 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-08-15−2,969→ 29,688 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2024-06-04+150,647→ 183,009 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2024-06-04+195,000→ 195,000 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-05-15+2,968→ 19,956 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-05-15−2,968→ 32,657 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-05-15$0.94/sh−939→ 19,017 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-02-16$1.08/sh−4,400→ 16,988 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-02-15−11,875→ 35,625 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2024-02-15+11,875→ 21,388 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2024-02-14+213,750→ 213,750 total
Award
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2024-02-14+35,625→ 35,625 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2024-02-14+287,905→ 287,905 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2023-10-30$1.35/sh−4,232→ 9,513 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2023-10-27−13,745→ 13,744 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2023-10-27+13,745→ 13,745 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2023-06-01+44,961→ 44,961 total
Award
Tvardi Therapeutics, Inc.$TVRD
Common Stock
2023-06-01+32,362→ 32,362 total
Award
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2023-04-27+27,489→ 27,489 total
Award
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2023-02-03+47,500→ 47,500 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2023-02-03+95,000→ 95,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (Right to Buy)
2023-01-02+45,841→ 45,841 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2022-02-04+175,000→ 175,000 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2021-02-04+110,000→ 110,000 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2020-04-06+325,000→ 325,000 total

Companies

Recent Filings

Address

C/O ZENAS BIOPHARMA, INC. 852 WINTER ST., SUITE 250

WALTHAM, MA, 02451

View on SEC.gov